U.S. RESEARCH ROUNDUP-Akero Therapeutics, Bristol-Myers Squibb, Merck & Co

Taskus

14/09/2022 08:19

Sept 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Akero Therapeutics, Bristol-Myers Squibb and Merck &
Co, on Wednesday. 
    
    HIGHLIGHTS
     * Akero Therapeutics Inc  AKRO.O : Evercore ISI raises to outperform from in line
     * Bristol-Myers Squibb Co  BMY.N : Berenberg cuts to hold from buy    
     * Merck & Co Inc  MRK.N : Berenberg raises to buy from hold
     * Netstreit Corp  NTST.N : Raymond James initiates coverage with strong buy rating         
        
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday.
Stock entries are in alphabetical order. 
    
     * 89Bio Inc  ETNB.O : Raymond James raises target price to $25 from $14 
     * Agilon Health Inc  AGL.N : RBC initiates coverage with outperform rating and $33 PT 
     * Akero Therapeutics Inc  AKRO.O : Evercore ISI raises to outperform from in line
     * Akero Therapeutics Inc  AKRO.O : Evercore ISI raises target price to $50 from $10 
     * Alpine Immune Sciences Inc  ALPN.O : Wedbush raises target price to $25 from $22 
     * Avantor Inc  AVTR.N : Citigroup cuts price target to $28 from $32 
     * Bristol-Myers Squibb Co  BMY.N : Berenberg cuts to hold from buy
     * Bristol-Myers Squibb Co  BMY.N : Berenberg cuts target price to $76 from $82 
     * Cheniere Energy Inc  LNG.A : RBC raises target price to $199 from $184 
     * Church & Dwight Co Inc  CHD.N : Jefferies cuts target price to $98 from $101 
     * Coinbase Global Inc  COIN.O : JP Morgan raises target price to $78 from $64 
     * Core & Main Inc  CNM.N : Citigroup raises price target to $26 from $25 
     * Core & Main Inc  CNM.N : Credit Suisse raises target price to $32 from $29 
     * Core & Main Inc  CNM.N : Truist Securities raises target price to $28 from $25 
     * Corteva Inc  CTVA.N : JP Morgan raises target price to $65 from $63 
     * Farmland Partners Inc  FPI.N : Raymond James raises target price to $17 from $15 
     * Flowserve Corp  FLS.N : RBC cuts target price to $31 from $33 
     * Gilead Sciences Inc  GILD.O : RBC raises target price to $83 from $79 
     * Groupon Inc  GRPN.O : Ascendiant Capital Markets cuts target price to $18 from $20 
     * Merck & Co Inc  MRK.N : Berenberg raises to buy from hold
     * Merck & Co Inc  MRK.N : Berenberg raises target price to $100 from $95 
     * Netstreit Corp  NTST.N : Raymond James initiates coverage with strong buy rating 
     * Netstreit Corp  NTST.N : Raymond James initiates coverage with $24 target price 
     * Newell Brands Inc  NWL.O : Jefferies cuts target price to $28 from $34 
     * Oracle Corp  ORCL.N : Berenberg initiates coverage with hold rating and $72 price target 
     * Pfizer Inc  PFE.N : Berenberg cuts target price to $44 from $50 
     * RH  RH.N : JP Morgan raises target price to $325 from $300 
     * Taskus Inc  TASK.O : RBC cuts target price to $26 from $36 
     * TD Synnex Corp  SNX.N : Credit Suisse cuts target price to $110 from $115 
     * Tripadvisor Inc  TRIP.O : Ascendiant Capital Markets cuts target price to $35 from $36 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))